It inhibits tumor cell proliferation by blocking the cell cycle at the G1 and G2 phases and inducing apoptosis.621 Its efficacy was observed independently of histotype, p53 status, and multidrug resistance status. The gene discussed is TP53; the disease is neoplasm.